Manufacturer record
Spas Remedise: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Spas Remedise (Himachal Pradesh) were declared Not of Standard Quality between August 2019 and February 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Spas Remedise in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Fevanex Rapid - 650[ Paracetamol Tab IP 650 mg] | SRGT- 24471Mfg 2024-08 · Exp 2026-07 | It fails the test ?Dissolution? Specified in the laboratory protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Feb 2025 |
| Roxclave-625 Tablets (Amoxycillin & Potassium Clavulanate Tablets I.P.) | SRBT-22280Mfg 2022-06 · Exp 2023-11 | Identification of Potassium Clavulanate, Assay of Amoxycillin as well as DissolutionAssay | RDTL GuwahatiState lab | Feb 2023 |
| Cecon ? XT Tablets (Ferrous Ascorbate, Folic Acid, Vitamin B12 & Zinc Tablets) | SRDT ? 1207Mfg 2019-05 · Exp 2020-10 | Assay/Content of ?Folic Acid, Elemental Iron and Elemental ZincAssay | CDL KolkataCDSCO lab | Feb 2020 |
| MOXCON-CV 625 (Amoxycillin & Potassium Clavulanate Tablets I.P.) | SRDTB-1233Mfg 2019-06 · Exp 2020-11 | Dissolution, Water & Assay of Potassium ClavulanateAssay | CDL KolkataCDSCO lab | Aug 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.